Clinical Trial

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative effectiveness of EHR alerts on PCPs' referral patterns.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-18.
Trial Details
NCT Number NCT07431931
Lead Sponsor Geisinger Clinic
Collaborators: Novartis
Conditions Referral and Consultation, Glomerulonephritis, Hematuria, Proteinuria, Kidney Disease
Enrollment 1,200 participants
Start Date 2026-11
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-12